Balaxi Pharmaceuticals Share Price | Balaxi Pharmaceuticals Stock Screener
BALAXI
Pharmaceuticals
Share Price NSE
₹26.37
▲
0.80 (3.13%)
As of April 17, 2026, the Balaxi Pharmaceuticals share price (NSE: BALAXI) is ₹26.37, up 3.13% from the previous close, with shares trading between ₹25.72 and ₹26.97, and a 52-week range of ₹15.67–₹50.06.
Analyse Balaxi Pharmaceuticals share price performance and track historical price performance.
Use the Balaxi Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Balaxi Pharmaceuticals Market Cap
₹132.44 Cr.
BALAXI P/E Ratio (TTM)
91.96
Balaxi Pharmaceuticals P/B Ratio
0.53
EPS (TTM)
₹0.26
Dividend Yield
-
Debt to Equity
0.17
BALAXI 52 Week High
₹50.06
Balaxi Pharmaceuticals 52 Week Low
₹15.67
Operating Margin
-
Profit Margin
1.35%
BALAXI Revenue (TTM)
₹74.00
EBITDA
₹3.00
Net Income
₹1.00
Total Assets
₹337.00
Total Equity
₹249.00
Balaxi Pharmaceuticals Share Price Chart
Screen Balaxi Pharmaceuticals share price with an interactive chart. Analyse BALAXI price trends and volatility across different timeframes.
Balaxi Pharmaceuticals Company Profile - Fundamental Screener
Screen Balaxi Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BALAXI shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE618N01022
Balaxi Pharmaceuticals Balance Sheet Screener
Screen BALAXI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 337 | 310 | 258 | 240 | 177 | 100 | 36 | 6 |
| Current Assets | 251 | 243 | 210 | 194 | 141 | 94 | 35 | 6 |
| Fixed Assets | 49 | 41 | 41 | 41 | 29 | 2 | 0 | 0 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 26 | 24 | 3 | 4 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 249 | 232 | 201 | 183 | 113 | 65 | 28 | 4 |
| Share Capital | 11 | 11 | 11 | 10 | 10 | 10 | 10 | 3 |
| Reserves & Surplus | 238 | 221 | 187 | 162 | 103 | 55 | 18 | 1 |
Balaxi Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Balaxi Pharmaceuticals income statement and profit fundamentals.
Analyze BALAXI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Balaxi Pharmaceuticals share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 74 | 75 | 69 | 58 | 73 | 59 | 64 | 73 | 77 | 81 | 65 | 61 | 62 | 93 | 86 |
| Expenses | 71 | 64 | 67 | 55 | 69 | 46 | 56 | 67 | 69 | 68 | 104 | 44 | 47 | 78 | 69 |
| EBITDA | 3 | 11 | 2 | 3 | 3 | 13 | 8 | 7 | 8 | 13 | -39 | 17 | 15 | 15 | 17 |
| Operating Profit % | 0.00% | 16.00% | 6.00% | 2.00% | 4.00% | 23.00% | 15.00% | 14.00% | 5.00% | 16.00% | -57.00% | 20.00% | 22.00% | 13.00% | 17.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 10 | 1 | 1 | 2 | 12 | 7 | 6 | 6 | 11 | -39 | 16 | 14 | 15 | 17 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 1 | 1 | 2 | 3 |
| Net Profit | 1 | 9 | 0 | 0 | 0 | 11 | 7 | 5 | 5 | 8 | -41 | 14 | 14 | 13 | 14 |
| EPS | 0.11 | 1.56 | 0.05 | 0.04 | 0.06 | 10.41 | 1.17 | 0.84 | 0.97 | 8.01 | -40.49 | 14.10 | 13.29 | 12.71 | 14.15 |
Balaxi Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen BALAXI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | -35 | 5 | 6 | 34 | 0 | -14 | -2 |
| Investing Activities | -22 | -1 | -11 | -29 | -6 | 0 | 0 |
| Financing Activities | 34 | 30 | 26 | 0 | 4 | 18 | 0 |
| Net Cash Flow | -23 | 34 | 21 | 6 | -2 | 4 | -2 |
Balaxi Pharmaceuticals Shareholding Pattern Screener
See Balaxi Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Balaxi Pharmaceuticals promoter holding and ownership changes for BALAXI on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Apr | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% | 66.36% | 66.36% | 65.99% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 1.74% | 0.00% | 0.00% | 0.00% |
| DII Holding | 2.56% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.41% | 9.82% | 16.14% | 20.03% | 22.39% | 7.98% | 7.98% | 8.60% |
| Other Holding | 7.03% | 24.17% | 17.84% | 13.95% | 9.86% | 25.64% | 25.64% | 25.38% |
| Shareholder Count | 15,176 | 9,994 | 13,737 | 14,620 | 15,085 | 5,132 | 5,132 | 6,586 |
Balaxi Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Balaxi Pharmaceuticals dividend history with payout and yield data.
View Balaxi Pharmaceuticals dividend details including ex-dates and amounts for BALAXI stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.50 | 0.47% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Balaxi Pharmaceuticals Stock Index Membership
See which indices include Balaxi Pharmaceuticals stock.
Check BALAXI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Balaxi Pharmaceuticals Market Events Screener - Corporate Actions
Get Balaxi Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Balaxi Pharmaceuticals stock events that may affect BALAXI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -14.25% |
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | 2.45% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -3.16% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | -3.91% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -6.82% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 2.44% |
| 2024-11-05 | 2024-11-05 | Quarterly Result Announcement | NA | -1.03% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | -5.24% |
| 2024-05-30 | 2024-02-28 | Split | 2:10 | 0.00% |
| 2022-07-01 | 2022-07-04 | Dividend | ₹ 0.50 /share | -13.13% |
| 2020-10-07 | 2020-10-07 | Change Of Name | NA | 0.00% |
Balaxi Pharmaceuticals Competitors Screener - Peer Comparison
Screen BALAXI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,251 | 38.83 | 58,220 | 6.38% | 11,565 | 60.32 |
| Divis Laboratories | 173,869 | 68.00 | 10,560 | 8.73% | 2,520 | 44.73 |
| Torrent Pharmaceuticals | 155,844 | 73.17 | 13,886 | 20.34% | 2,138 | 62.27 |
| Cipla | 117,784 | 30.65 | 29,045 | 2.24% | 3,870 | 69.96 |
| Dr Reddys Laboratories | 112,689 | 27.24 | 33,593 | -0.44% | 3,998 | 66.21 |
| Zydus Life Science | 111,531 | 21.84 | 26,720 | 13.65% | 5,242 | 62.64 |
| Lupin | 109,654 | 20.66 | 27,488 | 19.98% | 5,345 | 68.05 |
| Mankind Pharma | 103,183 | 54.26 | 14,278 | 12.03% | 1,750 | 64.79 |
| Aurobindo Pharma | 89,978 | 26.13 | 33,385 | 3.21% | 3,376 | 69.05 |
| Laurus Labs | 80,698 | 92.10 | 6,868 | 22.01% | 890 | 72.35 |
Balaxi Pharmaceuticals Company Announcements - News Screener
Screen BALAXI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-01 | Trading Window | - |
| 2026-06-29 | Clarification - Financial Results | - |
| 2026-06-16 | Copy of Newspaper Publication | - |
| 2026-06-06 | Updates | - |
| 2026-05-30 | Copy of Newspaper Publication | - |
| 2026-05-29 | Investor Presentation | - |
| 2026-05-28 | Outcome of Board Meeting | - |
| 2026-05-28 | Outcome of Board Meeting | - |
| 2026-05-28 | Appointment | - |
| 2026-05-28 | Appointment | - |
| 2026-05-28 | Updates | - |
| 2026-05-12 | Updates | - |
| 2026-04-18 | Copy of Newspaper Publication | - |
| 2026-04-14 | Updates | - |
| 2026-04-13 | Disclosure under SEBI Takeover Regulations | - |
| 2026-04-10 | Disclosure under SEBI Takeover Regulations | - |
| 2026-04-09 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | - |
| 2026-04-09 | Price movement | - |
| 2026-04-08 | Price movement | - |
| 2026-04-02 | Credit Rating- Revision | - |